We were interested that galectin-3 regulates the Notch1 signaling pathway in ovarian cancer stem cells because Notch pathway genes might be important therapeutic targets for CSCs and many new agents targeting the Notch pathways have entered clinical trials [23]. The gene discussed is LGALS3; the disease is ovarian carcinoma.